| 24 HR diltiazem hydrochloride 120 MG Extended Release Oral Tablet diltiazem hydrochloride | 2,881 | 56.9%
| T2 | 0% | - |
| glucagon 3 MG Nasal Powder [Baqsimi] glucagon | 2,871 | 56.7%
| T3 | 0% | 40,142 |
| levalbuterol 0.103 MG/ML Inhalation Solution levalbuterol | 2,867 | 56.6%
| T3 | 99.2% | 6,922 |
| eltrombopag 12.5 MG Oral Tablet eltrombopag | 2,864 | 56.5%
| T4 | 99.2% | 5,708 |
| eltrombopag 25 MG Oral Tablet eltrombopag | 2,864 | 56.5%
| T4 | 99.2% | 5,708 |
| eltrombopag 50 MG Oral Tablet eltrombopag | 2,864 | 56.5%
| T4 | 99.2% | 5,708 |
| eltrombopag 75 MG Oral Tablet eltrombopag | 2,864 | 56.5%
| T4 | 99.2% | 5,708 |
| terbutaline sulfate 2.5 MG Oral Tablet terbutaline sulfate | 2,857 | 56.4%
| T3 | 0% | 1,087 |
| terbutaline sulfate 5 MG Oral Tablet terbutaline sulfate | 2,857 | 56.4%
| T3 | 0% | 1,087 |
| levalbuterol 2.5 MG/ML Inhalation Solution levalbuterol | 2,845 | 56.1%
| T3 | 99.2% | 6,922 |
| eltrombopag 12.5 MG Powder for Oral Suspension eltrombopag | 2,845 | 56.1%
| T4 | 99.2% | 5,708 |
| eltrombopag 25 MG Powder for Oral Suspension eltrombopag | 2,845 | 56.1%
| T4 | 99.2% | 5,708 |
| hydrocortisone valerate 2 MG/ML Topical Cream hydrocortisone valerate | 2,833 | 55.9%
| T2 | 0% | 15,376 |
| calcium chloride 0.2 MG/ML / glucose 50 MG/ML / potassium chloride 1.79 MG/ML / sodium chloride 6 MG/ML / sodium lactate 3.1 MG/ML Injectable Solution calcium chloride | 2,829 | 55.8%
| T3 | 0.7% | 108,459 |
| posaconazole 40 MG/ML Oral Suspension posaconazole | 2,821 | 55.7%
| T4 | 88.1% | 8,353 |
| polymyxin B 250000 UNT/ML Injectable Solution polymyxin B | 2,814 | 55.5%
| T3 | 6.5% | 334,644 |
| rifaximin 200 MG Oral Tablet [XIFAXAN] rifaximin | 2,813 | 55.5%
| T3 | 89.4% | 96,011 |
| perampanel 2 MG Oral Tablet [FYCOMPA] perampanel | 2,810 | 55.5%
| T4 | 61.1% | 6,343 |
| perampanel 4 MG Oral Tablet [FYCOMPA] perampanel | 2,810 | 55.5%
| T4 | 61.1% | 6,343 |
| perampanel 6 MG Oral Tablet [FYCOMPA] perampanel | 2,810 | 55.5%
| T4 | 61.1% | 6,343 |
| perampanel 8 MG Oral Tablet [FYCOMPA] perampanel | 2,810 | 55.5%
| T4 | 61.1% | 6,343 |
| perampanel 10 MG Oral Tablet [FYCOMPA] perampanel | 2,810 | 55.5%
| T4 | 61.1% | 6,343 |
| perampanel 12 MG Oral Tablet [FYCOMPA] perampanel | 2,810 | 55.5%
| T4 | 61.1% | 6,343 |
| besifloxacin 6 MG/ML Ophthalmic Suspension [Besivance] besifloxacin | 2,808 | 55.4%
| T3 | 0.7% | 30,725 |
| dipyridamole 25 MG Oral Tablet dipyridamole | 2,805 | 55.4%
| T2 | 42% | 3,216 |
| dipyridamole 50 MG Oral Tablet dipyridamole | 2,805 | 55.4%
| T2 | 42% | 3,216 |
| dipyridamole 75 MG Oral Tablet dipyridamole | 2,805 | 55.4%
| T2 | 42% | 3,216 |
| {4 (risedronate sodium 35 MG Delayed Release Oral Tablet) } Pack risedronate sodium | 2,802 | 55.3%
| T3 | 0% | - |
| {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Loestrin Fe 1/20 28 Day] ethinyl estradiol | 2,797 | 55.2%
| T2 | 0% | - |
| {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) } Pack [Loestrin 1.5/30 21 Day] ethinyl estradiol | 2,797 | 55.2%
| T2 | 0% | - |
| {21 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) } Pack [Loestrin 1/20 21 Day] ethinyl estradiol | 2,797 | 55.2%
| T2 | 0% | - |
| 1.56 ML abaloparatide 2 MG/ML Pen Injector [Tymlos] abaloparatide | 2,796 | 55.2%
| T4 | 88.1% | 12,979 |
| naproxen 500 MG Delayed Release Oral Tablet naproxen | 2,791 | 55.1%
| T2 | 0% | 1,344,536 |
| brimonidine tartrate 2 MG/ML / timolol 5 MG/ML Ophthalmic Solution brimonidine tartrate | 2,772 | 54.7%
| T2 | 0% | 573,214 |
| diclofenac sodium 0.03 MG/MG Topical Gel diclofenac sodium | 2,771 | 54.7%
| T3 | 73.4% | 3,196,668 |
| insulin, regular, human 500 UNT/ML Injectable Solution [Humulin R] insulin, regular, human | 2,770 | 54.7%
| T3 | 49.3% | 418,431 |
| {224 (tobramycin 28 MG Inhalation Powder [Tobi]) } Pack [TOBI Podhaler Kit] tobramycin | 2,766 | 54.6%
| T4 | 50.5% | - |
| eszopiclone 2 MG Oral Tablet eszopiclone | 2,763 | 54.5%
| T2 | 17.5% | 149,281 |
| eszopiclone 1 MG Oral Tablet eszopiclone | 2,763 | 54.5%
| T2 | 17.5% | 149,281 |
| niacin 500 MG Oral Tablet [Niacor] niacin | 2,761 | 54.5%
| T3 | 0% | 42,698 |
| eszopiclone 3 MG Oral Tablet eszopiclone | 2,755 | 54.4%
| T2 | 18% | 149,281 |
| epoetin alfa-epbx 20000 UNT/ML Injectable Solution [Retacrit] epoetin alfa-epbx | 2,754 | 54.4%
| T3 | 98.4% | 12,187 |
| ramelteon 8 MG Oral Tablet ramelteon | 2,749 | 54.3%
| T3 | 0% | 52,872 |
| acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet acetaminophen | 2,749 | 54.3%
| T2 | 35.7% | 156 |
| suvorexant 5 MG Oral Tablet [Belsomra] suvorexant | 2,747 | 54.2%
| T3 | 24.8% | 86,387 |
| suvorexant 10 MG Oral Tablet [Belsomra] suvorexant | 2,747 | 54.2%
| T3 | 24.8% | 86,387 |
| suvorexant 15 MG Oral Tablet [Belsomra] suvorexant | 2,747 | 54.2%
| T3 | 24.8% | 86,387 |
| suvorexant 20 MG Oral Tablet [Belsomra] suvorexant | 2,747 | 54.2%
| T3 | 24.8% | 86,387 |
| 0.2 ML adalimumab 100 MG/ML Prefilled Syringe [Humira] adalimumab | 2,743 | 54.1%
| T4 | 100% | 4,742 |
| 0.1 ML adalimumab 100 MG/ML Prefilled Syringe [Humira] adalimumab | 2,743 | 54.1%
| T4 | 100% | 4,742 |
| {28 (estrogens, conjugated (USP) 0.3 MG / medroxyprogesterone acetate 1.5 MG Oral Tablet) } Pack [Prempro 0.3/1.5 28 Day] estrogens, | 2,743 | 54.1%
| T3 | 17.8% | - |
| {28 (estrogens, conjugated (USP) 0.45 MG / medroxyprogesterone acetate 1.5 MG Oral Tablet) } Pack [Prempro 0.45/1.5 28 Day] estrogens, | 2,743 | 54.1%
| T3 | 17.8% | - |
| {28 (estrogens, conjugated (USP) 0.625 MG / medroxyprogesterone acetate 2.5 MG Oral Tablet) } Pack [Prempro 0.625/2.5 28 Day] estrogens, | 2,743 | 54.1%
| T3 | 17.8% | - |
| {28 (estrogens, conjugated (USP) 0.625 MG / medroxyprogesterone acetate 5 MG Oral Tablet) } Pack [Prempro 0.625/5 28 Day] estrogens, | 2,743 | 54.1%
| T3 | 17.8% | - |
| niacin 500 MG Oral Tablet niacin | 2,739 | 54.1%
| T2 | 0% | 42,698 |
| benzoyl peroxide 0.05 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel benzoyl peroxide | 2,739 | 54.1%
| T2 | 0% | 465 |
| {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Loestrin Fe 1.5/30 28 Day] ethinyl estradiol | 2,734 | 54%
| T2 | 0% | - |
| minocycline 50 MG Oral Tablet minocycline | 2,728 | 53.8%
| T3 | 0% | 158,316 |
| cycloserine 250 MG Oral Capsule cycloserine | 2,725 | 53.8%
| T4 | 0.9% | - |
| 20 ML immunoglobulin G, human 100 MG/ML Injection [Octagam] immunoglobulin G, human | 2,719 | 53.7%
| T4 | 100% | 2,511 |
| minocycline 75 MG Oral Tablet minocycline | 2,714 | 53.6%
| T3 | 0% | 158,316 |
| alendronic acid 0.933 MG/ML Oral Solution alendronic acid | 2,703 | 53.3%
| T2 | 0% | - |
| ivabradine 1 MG/ML Oral Solution [Corlanor] ivabradine | 2,699 | 53.3%
| T3 | 40.8% | 12,415 |
| trientine hydrochloride 500 MG Oral Capsule trientine hydrochloride | 2,699 | 53.3%
| T4 | 62.5% | - |
| cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis] cyclosporine | 2,698 | 53.2%
| T3 | 0% | 492,479 |
| 24 HR tacrolimus 0.5 MG Extended Release Oral Capsule [Astagraf] tacrolimus | 2,695 | 53.2%
| T3 | 100% | - |
| 24 HR tacrolimus 1 MG Extended Release Oral Capsule [Astagraf] tacrolimus | 2,695 | 53.2%
| T3 | 100% | - |
| 24 HR tacrolimus 5 MG Extended Release Oral Capsule [Astagraf] tacrolimus | 2,695 | 53.2%
| T4 | 100% | - |
| hydromorphone hydrochloride 1 MG/ML Oral Solution hydromorphone hydrochloride | 2,689 | 53.1%
| T3 | 1.5% | 234,154 |
| 0.2 ML glucagon 5 MG/ML Auto-Injector [Gvoke] glucagon | 2,688 | 53%
| T3 | 0% | 1,079 |
| 0.2 ML glucagon 5 MG/ML Prefilled Syringe [Gvoke] glucagon | 2,688 | 53%
| T3 | 0% | 1,079 |
| nitroglycerin 0.4 MG/ACTUAT Mucosal Spray nitroglycerin | 2,686 | 53%
| T3 | 0% | 1,348,161 |
| 24 HR fesoterodine fumarate 4 MG Extended Release Oral Tablet fesoterodine fumarate | 2,682 | 52.9%
| T3 | 0.5% | - |
| 24 HR fesoterodine fumarate 8 MG Extended Release Oral Tablet fesoterodine fumarate | 2,682 | 52.9%
| T3 | 0.5% | - |
| 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler | 2,677 | 52.8%
| T3 | 0% | - |
| 120 ACTUAT budesonide 0.08 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler | 2,677 | 52.8%
| T3 | 0% | - |
| 0.1 ML glucagon 5 MG/ML Auto-Injector [Gvoke] glucagon | 2,672 | 52.7%
| T3 | 0% | 1,079 |
| belumosudil 200 MG Oral Tablet [Rezurock] belumosudil | 2,666 | 52.6%
| T4 | 99.2% | - |
| 0.2 ML glucagon 5 MG/ML Injection [Gvoke] glucagon | 2,662 | 52.5%
| T3 | 0% | 1,079 |
| mexiletine hydrochloride 150 MG Oral Capsule mexiletine hydrochloride | 2,658 | 52.5%
| T3 | 0% | 20,421 |
| difluprednate 0.5 MG/ML Ophthalmic Suspension difluprednate | 2,657 | 52.4%
| T3 | 0% | 69,636 |
| 120 ACTUAT budesonide 0.08 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler [Breyna] | 2,652 | 52.3%
| T3 | 0% | 22,119 |
| 120 ACTUAT budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler [Breyna] | 2,652 | 52.3%
| T3 | 0% | 22,119 |
| insulin lispro 100 UNT/ML Injectable Solution insulin lispro | 2,648 | 52.3%
| T3 | 18.3% | 418,431 |
| mexiletine hydrochloride 250 MG Oral Capsule mexiletine hydrochloride | 2,648 | 52.3%
| T3 | 0% | 20,421 |
| azilsartan medoxomil 40 MG / chlorthalidone 12.5 MG Oral Tablet [Edarbyclor] azilsartan medoxomil | 2,643 | 52.2%
| T3 | 0% | 17,111 |
| azilsartan medoxomil 40 MG / chlorthalidone 25 MG Oral Tablet [Edarbyclor] azilsartan medoxomil | 2,643 | 52.2%
| T3 | 0% | 17,111 |
| 1 ML epoetin alfa-epbx 2000 UNT/ML Injection [Retacrit] epoetin alfa-epbx | 2,643 | 52.2%
| T3 | 99.2% | 12,187 |
| 1 ML epoetin alfa-epbx 3000 UNT/ML Injection [Retacrit] epoetin alfa-epbx | 2,643 | 52.2%
| T3 | 99.2% | 12,187 |
| 1 ML epoetin alfa-epbx 4000 UNT/ML Injection [Retacrit] epoetin alfa-epbx | 2,643 | 52.2%
| T3 | 99.2% | 12,187 |
| 1 ML epoetin alfa-epbx 10000 UNT/ML Injection [Retacrit] epoetin alfa-epbx | 2,643 | 52.2%
| T3 | 99.2% | 12,187 |
| mesalamine 400 MG Delayed Release Oral Capsule mesalamine | 2,638 | 52.1%
| T3 | 0% | 95,185 |
| mexiletine hydrochloride 200 MG Oral Capsule mexiletine hydrochloride | 2,635 | 52%
| T3 | 0% | 20,421 |
| epoetin alfa-epbx 10000 UNT/ML Injectable Solution [Retacrit] epoetin alfa-epbx | 2,635 | 52%
| T3 | 99.2% | 12,187 |
| 1 ML somatropin 5 MG/ML Cartridge [Genotropin] somatropin | 2,634 | 52%
| T4 | 100% | 1,572 |
| 1 ML somatropin 12 MG/ML Cartridge [Genotropin] somatropin | 2,634 | 52%
| T4 | 100% | 1,572 |
| bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 10 UNT/MG Ophthalmic Ointment [Neo-Polycin] bacitracin | 2,633 | 52%
| T2 | 0% | 14,794 |
| 24 HR apremilast 75 MG Extended Release Oral Tablet [Otezla] apremilast | 2,629 | 51.9%
| T4 | 100% | 26,811 |
| 50 ML penicillin G potassium 40000 UNT/ML Injection penicillin G potassium | 2,628 | 51.9%
| T3 | 15.2% | - |
| 50 ML penicillin G potassium 60000 UNT/ML Injection penicillin G potassium | 2,628 | 51.9%
| T3 | 15.2% | - |